A Bad Fit: Dan Leonard’s Leadership Style Did Not Translate At AAM

Former employees at the Association for Accessible Medicines detail problems that emerged during Leonard’s tenure, but also say the board of directors must improve its management of the trade organization.

generic exit
Dan Leonard resigned as AAM CEO on 5 December 2022 • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock images

The Association for Accessible Medicines’ former CEO Dan Leonard embraced a “hands-off” style of management, allowing employees to complete their and the organization’s tasks without interference.

That style may have worked when he led the National Pharmaceutical Council, a health policy research and communication organization, but...

More from Leadership

More from Generics Bulletin

Zentiva Strikes Deal With Aboca To Expand CHC Offering

 
• By 

Czech Republic's Zentiva snaps up Aboca portfolio adding supplement brands marketed in European countries such France, Italy and Spain.

Will Amarin Finally Launch An Authorized Generic Version Of Vascepa?

 
• By 

As it offloads commercial rights to the brand in Europe, Amarin has for the umpteenth time teased the possibility of launching an authorized generic version of Vascepa in the US.

Bio-Thera And SteinCares Add Mega-Blockbuster Dupilumab To Latin America Alliance

 
• By 

Bio-Thera Solutions is back with its third agreement with Costa Rica-based SteinCares for the supply of a biosimilar in Latin America – this time for the Chinese firm’s proposed rival to Sanofi and Regeneron’s Dupixent (dupilumab)